Lisinopril
규격
76547-98-3CAS 번호
278-488-1EC 번호
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acidIUPAC 명칭
C21H31N3O5화학식
405.5 g/mol분자량
lisinopril; 76547-98-3; Prinivil; Zestril; Lisinopril anhydrous; Lysinopril; Carace; Novatec; Lisinoprilum; Lisinoprilum [Latin]; Qbrelis; 7Q3P4BS2FD; MK-521; [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE; N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; L-Proline, N2-((1S)-1-carboxy-3-phenylpropyl)-L-lysyl-; DTXSID6040537; (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline; CHEBI:43755; Lisinoprilum (Latin); L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-; NSC-751176; NSC-758151; (2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; L-PROLINE, 1-(N(SUP 2)-(1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL)-; 1-(N(SUP 2)-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL)-L-PROLINE; (2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid; (N2-((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline; L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-; Lisinoril; Lisopress; (2S)-1-((2S)-6-amino-2-(((1S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid; (2S)-1-((2S)-6-amino-2-(((2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl)amino)hexanoyl)pyrrolidine-2-carboxylic acid; L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-; RefChem:5952; L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-; DTXCID4020537; C09AA03; N2-((1S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline, Dihydrate; 278-488-1; E7199S1YWR; Ranolip; Linopril; Tensopril; Acercomp; Inhibril; Lisipril; Noperten; Presiten; Sinopril; Acerbon; Vivatec; Coric; Alapril; Inopril; Lisinal; Lisoril; Lispril; Sinopryl; Cipral; Cipril; Linvas; Lipril; Longes; Loril; Prinil; Tensyn; Tersif; 83915-83-7; Hipril; Lisinopril (INN); Lisinopril [INN]; (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid; Zestril (TN); MFCD00214086; C21H31N3O5; LPR; (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; Nanopril; CHEMBL1237; (S)-Lisinopril Dihydrate; N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; Lizinopril; Diroton; Lisitec; Lisopril; Listril; Lizonoton; Optimon; Prinvil; Skopryl; Vitopril; Amicor; Doneka; Irumed; Laaven; N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; MK 521; MK 522; SMR000544473; CCRIS 3568; EINECS 278-488-1; UNII-7Q3P4BS2FD; BRN 4276619; L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-; lysinopryl; (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline; Zestoretic;; Acercomp;; Prinivil;; Prinzide;; Acecomb;; Acerbon;; Alapril;; Novatec;; Novazyd;; Vivatec;; Carace;; Longes;; HSDB 6852; Coric;; (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; (S)-1-[(S)-6-Amino-2-[[(S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic Acid; (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate; 1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; Spectrum_000497; LISINOPRIL [MI]; Prestwick0_000301; Prestwick1_000301; Prestwick2_000301; Prestwick3_000301; Spectrum2_001456; Spectrum3_000941; Spectrum4_001040; Spectrum5_000995; LISINOPRIL [WHO-DD]; SCHEMBL15680; BSPBio_000262; KBioGR_001599; KBioSS_000977; MLS001306436; MLS001306481; BIDD:GT0755; DivK1c_001037; SPECTRUM1501217; SPBio_001351; SPBio_002481; BPBio1_000290; GTPL6360; ICI-209K; orb1306371; HMS503O15; KBio1_001037; KBio2_000977; KBio2_003545; KBio2_006113; KBio3_002002; N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; NINDS_001037; HMS1921B14; HMS2090O14; HMS2092L21; HMS2850N20; Pharmakon1600-01501217; 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline; BDBM50367879; CCG-39190; DL-434; EBC-02057; NSC751176; NSC758151; AKOS015836369; AKOS015894970; L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-; DB00722; IDI1_001037; NCGC00179623-01; NCGC00179623-07; (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; HY-18206; SY468011; SBI-0051692.P002; L0220; NS00009977; C76449; D08131; T21418; AB00052250-13; AB00052250_14; AB00052250_15; F826606; Q412208; SR-05000001786; SR-05000001786-1; BRD-K67966701-001-10-8; BRD-K67966701-001-11-6; BRD-K67966701-001-12-4; BRD-K67966701-335-03-5; Z1515376765; N-[N2 (1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline; N-[N2 -(1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline; Lisinopril Dihydrate Working Standard (Secondary Reference Standard)동의어
Lisinopril 함유 제품
ZESTRIL 20 mg COMPRIMIDOSZESTORETIC 20 mg/12,5 mg COMPRIMIDOSTENSIKEY COMPLEX 20 mg/12.5 mg COMPRIMIDOSLISINOPRIL TEVA-RATIOPHARM 20 mg COMPRIMIDOS EFGPRINIVIL 5 mg COMPRIMIDOSPRINIVIL 20 mg COMPRIMIDOSPRINIVIL PLUS 20 mg/12,5 mg COMPRIMIDOSLISINOPRIL CINFA 5 mg COMPRIMIDOS EFGLISINOPRIL CINFA 20 mg COMPRIMIDOS EFGLisoril-5Auroliza 10Auroliza 20
